Medical care in Asia: how Japan, Korea, Singapore, Thailand and China compare

The table separates observation years rather than relabelling old data as 2026 figures. Doctors include generalists and specialists; hospital beds also serve rehabilitation and longer-term care. Spending uses 2023 purchasing-power-adjusted international dollars. Singapore’s higher spending describes the resources consumed by its health system, not a visitor’s treatment price.

China’s structure is particularly easy to misread from hospital counts. In 2024, 4,111 of its 38,710 hospitals were tertiary institutions: roughly 11% of hospitals held 48% of hospital beds. The tertiary tier is therefore central to a search for hospital-based specialist care. The figures describe concentration by institutional level; they do not mean every tertiary hospital offers the same procedures or outcomes.

Ownership also means different things across borders. An OECD review published in 2022 reported that about 94% of Korean hospitals were privately owned. Private provision there is part of the mainstream insured system. Singapore, by contrast, identifies ten national specialty centres spanning fields including cancer, heart disease, eye care, neuroscience and dentistry. These named centres give an overseas patient a more explicit specialty map than a general list of hospitals.

Thailand’s WHO workforce profile describes geographical and sectoral imbalances, with professionals concentrated in urban areas and the private sector. Its national doctor average should not be used to describe the staffing of a Bangkok private hospital. Conversely, the services of a prominent international hospital cannot stand in for healthcare access across Thailand.

These are age- and sex-standardised deaths per 100 admissions among people aged 45 or older, within 30 days and in the same hospital. Transfers and deaths after discharge are not fully captured. Case severity, emergency transport and discharge practices also affect the comparison. China and Thailand are absent from these harmonised figures; substituting a selected hospital study would make the comparison misleading.

Singapore’s Ministry of Health lets patients search by condition or procedure code. Its published private hospital benchmarks apply to specified services and, for inpatient hospital fees, one-bedded wards; doctor fees and hospital fees need to be distinguished. Unusually complex or severely ill cases can fall outside the reference scope. The practical advantage is a government reference against which an itemised quote can be read, rather than a guaranteed all-inclusive price.

Japan illustrates why “the national price” needs qualification. Insurance fees normally use ¥10 per point. A March 2026 rule allows specified hospital corporations, including social medical corporations, to set uninsured foreign-visitor prices up to ¥30 per point, subject to a regional standard ceiling and administrative confirmation. This is a narrowly defined rule for those corporations, not a nationwide threefold surcharge or a cap applying to every provider.

China’s public medical-service prices are government-guided and administered through regional pricing arrangements. Non-public institutions use market-adjusted prices. A public hospital’s ordinary service, its international service and a private hospital therefore need not share one tariff. The financing model also leaves separate components such as medicines and consumables: the listed price of a procedure is not automatically the complete episode cost.

Thailand’s Department of Internal Trade describes a national reporting framework covering hospital medicine and supply prices, medical-service fees and other charges. Its 2024 report also describes informing patients of prices before sale or service on request. This provides a basis for price disclosure, rather than one national treatment tariff. In Korea, national insurance and predominantly private ownership coexist; neither ownership nor an insured fee schedule establishes what an uninsured visitor will be charged.

For Japan’s medical-stay visa route, the applicant works through a registered guarantor and supplies a hospital certificate describing the planned care, a guarantor reference and evidence of financial means. Stays exceeding 90 days require hospitalisation and a Certificate of Eligibility. These rules describe that visa route; they do not mean every visitor receiving care must use it. Japan’s designated cancer-hospital network and international-patient directories provide separate tools for locating services.

Korea requires registered medical providers serving foreign patients to carry malpractice-liability insurance. Registration status can also be checked separately for facilitators; it does not certify comparative treatment results. National Health Insurance eligibility is a separate matter based on employment or qualifying residence status, including a six-month residence rule for many local subscribers. A short medical trip should not be budgeted as if the patient had resident benefits.

Singapore’s public acute-inpatient subsidies are for citizens and permanent residents. Being admitted to a public institution does not give an overseas visitor those subsidies. Thailand’s universal-coverage arrangements likewise concern eligible populations rather than automatically insuring medical tourists. In China, eligible foreign employees participate in social insurance, but an overseas self-pay patient has a different financial position. International services may add translation and coordination to a hospital visit; those services and their charges must be distinguished from the underlying clinical department.

The strongest national-level distinction is therefore practical: Japan offers a formal medical-stay coordination route; Korea a regulated foreign-patient recruitment channel; Singapore a clearly mapped specialist network and published fee references; Thailand a dual public-coverage and private-care environment; China a large tertiary-hospital base with regionally administered public pricing. Those differences establish the search strategy before individual hospitals enter the comparison.